A randomized prospective crossover trial of amlodipine in pediatric hypertension

Pediatric Nephrology

Volumn 14, Issue 12, 2000, Pages 1083-1087

  Rogan, J W ^a   Lyszkiewicz, D A ^a   Blowey, D ^b   Khattak, S ^a   Arbus, G S ^a   Koren, G ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Amlodipine; Calcium channel blockers; Felodipine; Hypertension; Nifedipine; Pediatric hypertension; Prospective trial

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE; NIFEDIPINE;

ADOLESCENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CHILD; CROSS-OVER STUDIES; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; MALE; NIFEDIPINE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES;

EID: 0033818380     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670000400     Document Type: Article

References (39)

1. Significant diastolic hypertension in pre-high school black and white children: The children and adolescent blood pressure program
2. Epidemiology and measurement of high blood pressure in children and adolescents
3. Hypertension and the kidney
4. Hypertension after renal transplantation
5. Hypertension in renal transplant recipients
6. Analysis of hypertension in children post renal transplantation - A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
7. Prevalence, etiology, and treatment of late post-transplant hypertension
8. Mechanisms of post transplant hypertension
9. Hypertension in kidney transplant recipients
10. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis
11. Post-transplant hypertension and hypertensive encephalopathy in renal allograft recipients
12. Hypertension and kidney transplantation
13. Hypertension in renal transplant recipients on cyclosporine A and corticosteroids and azathioprine
14. Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent
15. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients
16. A single institution, randomized, prospective trial of cyclospotine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients
17. Complications of cyclosporine prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center from one to five years
18. Renal function and somatic growth in paediatric cadaveric renal transplantation with cyclosporine-prednisone immunosuppression
19. Hypertension after rehal transplantation: A comparison of cyclosporine and conventional immunosuppression
20. Hypertension following kidney transplantation
21. Cyclosporine augments renal but not systemic vascular reactivity
22. Cyclosporine in therapeutic doses increases renal allograft vascular resistance
23. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II
24. Therapeutic benefits of calcium channel blockers in cyclosporine treated organ transplant recipients: Blood pressure control and immunosuppression
25. Cyclosporine-induced hypertension after transplantation
26. Pathophysiology of cyclosporine A nephrotoxicity: Experimental and clinical observations
27. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion
28. Effects of isradipine on renal function in cyclosporine-treated renal transplant patients
29. Comparative effects of enalapril and nifedipine on renal hemodynamics in hypertensive renal allograft recipients
30. Systemic and renal effects of nifedipine in cyclosporine-associated hypertension
31. Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants
32. Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients
33. Potential applicability of calcium antagonists as renal protective agents
34. Hypertension in pediatric patients
35. Hypertension after renal transplantation. Calcium channel or converting enzyme blockade
36. Stability of amlodipine besylate in two liquid dosage forms
37. Comparison of early side-effects with amlodipine and nifedipine in hypertension
38. Felodipine compared to diltiazem as monotherapy in mild to moderate hypertension
39. Medication compliance